Olanzapine has been the most commonly studied psychotropic medication for children and adolescents with anorexia nervosa (AN). At present, only 1 double-blind placebo-controlled trial in this population has been published. Kafantaris and colleagues8examined olanzapine in 20 underweight adolescents being ...
A comparison of olanzapine with haloperidol in cannabis-induced psychotic disorder: a double-blind randomized controlled trial. Little controlled data exist on the treatment of substance induced psychotic disorders. In this study, 30 patients meeting DSM-IV criteria for cannabis ind... M Berk,S Broo...
This was an 8-week randomized, double-blind, placebo-controlled study of youth aged 10–17 where OFC was significantly superior to placebo in reducing symptoms of depression in this population (Detke et al., 2015). Until recently, OFC was the only medication with FDA-approval for ...
Olanzapine is a commonly prescribed atypical antipsychotic medication that frequently causes weight gain. To our knowledge, the neural correlates of this weight gain have not been adequately studied in humans. Objective To test the hypothesis that olanzapine treatment disrupts the neural activity ...
DISCUSSION This is the first study to examine the effects of any anti- psychotic drug on muscarinic receptor availability in vivo and the first to image [I-123]IQNB binding in schizo- phrenic patients on and off medication. We compared muscarinic receptor occupancy by the atypical neuro- l...
Halim ND, Lipska BK, Hyde TM, Deep-Soboslay A, Saylor EM, Herman MM, Thakar J, Verma A & Kleinman JE 2008 Increased lactate levels and reduced pH in postmortem brains of schizophrenics: medication confounds. Journal of Neuroscience Methods 169 208–213. (doi:10.1016/j.jneumeth.2007.11...
‘749 as an LAI treatment option for schizophrenia patients taking daily oral olanzapine or other antipsychotic medications. Currently, the only long-acting olanzapine treatment option for schizophrenia carries a risk for PDSS, the sudden and unexpected onset of delirium or sedation when medication is ...
OLZ/SAM can also be considered safer as compared to other treatment options because it is administered in the form of a single tablet hence avoiding any issues that are encountered when taking additional medication with a prescribed tablet i.e side effects and drug-drug interaction impact [35]...
A phase 3, multicenter, double-blind, randomized, placebo-controlled clinical trial to verify the efficacy and safety of ansofaxine (LY03005) for major depressive disorder ArticleOpen access10 May 2023 Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication ...
Although we found a significant difference in the effi- cacy of the medication among groups, the sample size of this study was small. Clinical trials with a larger sample size are required to confirm the results of this study in the future. Conclusion In this study, we found that in ...